Pharmacogenetics aligns current and future medications with each persons unique genetic profile.
The PGx Medical proprietary process impacts quality, adds value and addresses clinical concerns such as falls, dementia, sleep, pain, med management and overall staff efficiencies.
PGx Medical is looking for a select number of LTC/Senior communities in various States across the country to partner in a pilot program to help gain insight, feedback and data relevant to medication management and pharmacogenetics in the field of aging services. This pilot is not a study or clinical trial, but rather a pilot partnership with progressive LTC communities that are interested in exploring enhanced quality measures, improved outcomes and overall efficiencies in their communities. This is a fully reimbursed diagnostic pilot program that has no-cost to the community or the residents and provides valuable information for each individual resident that meets CMS criteria for medical necessity.
Presently enrolling provider organizations and communities to participate in this pharmacogenetics operational program. To learn more, contact us at info@pgxmed.com or 405-509-5112.